The Cambridge Prostate mpMRI & Biopsy Course is an established international workshop has traditionally addressed the approach to learning the skills required for this new diagnostic tool and its application using guided biopsies in a multidisciplinary environment involving Radiologists, Urologists and Pathologists.
Through a combination of lectures, practical cases, discussions and workshops the course sets out to share knowledge on the quality and advantages of the Prostate MRI which have re-defined prostate diagnostic practice in recent years. Modules for beginners and advanced readers will be provided.
Places for the course are limited and will be handled on a first come first serve basis. For more information please visit http://www.cambridge-mri-course.org/
Tremendous advancements have been made in diagnosis and treatment with the recent FDA approval of a targeted therapy for metastatic bladder cancer with FGFR3 or FGFR2 genetic alterations, two combination immunotherapy-targeted therapies as first-line treatment for advanced RCC, as well as advances in diagnostics and immunotherapy research for prostate cancer
Take advantage of this highly anticipated event and immerse yourself in the evolving landscape of urological cancer care.
For more information and to register, click here. Space is limited!
Prague, Czech Republic | 23rd to 25th January 2020
More information here.
To unite global urological clinical research through technology and collaboration.
To empower urologists to create insights in the outcomes of their treatment strategies and adjust their treatments based on data analysis.
To explore new avenues in clinical research including e-health.